Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy

Glioblastoma (GBM) is the most lethal primary brain tumor, and despite several refinements in its multimodal management, generally has very poor prognosis. Targeted immunotherapy is an emerging field of research that shows great promise in the treatment of GBM. One of the most extensively studied ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Sadhak, Thaci, Bart, Crawford, Andrew C., Sampath, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163479/
https://www.ncbi.nlm.nih.gov/pubmed/25247196
http://dx.doi.org/10.1155/2014/952128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163479/
https://www.ncbi.nlm.nih.gov/pubmed/25247196
http://dx.doi.org/10.1155/2014/952128

Ejemplares similares